Human leukocyte antigen-A24 and-DQA1*0301 in Japanese insulin-dependent diabetes mellitus:: Independent contributions to susceptibility to the disease and additive contributions to acceleration of β-cell destruction

被引:37
作者
Nakanishi, K
Kobayashi, T
Murase, T
Naruse, T
Nose, Y
Inoko, H
机构
[1] Toranomon Gen Hosp, Dept Endocrinol & Metab, Minato Ku, Tokyo 1058470, Japan
[2] Okinaka Mem Inst Med Res, Tokyo 1058470, Japan
[3] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 2591100, Japan
[4] Hyogo Red Cross Blood Ctr, Kobe, Hyogo 6510062, Japan
关键词
D O I
10.1210/jc.84.10.3721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to identify insulin-dependent diabetes mellitus (IDDM)-susceptible HLA antigens in IDDM patients who do not have established risk allele, HLA-DQA1*0301, and analyze relationship of these HLA antigens and the degree of beta-cell destruction. In 139 Japanese IDDM patients and 158 normal controls, HLA-A, -C, -B, -DR and -DQ antigens were typed. Serum C-peptide-immunoreactivity response (Delta CPR) to a 100-g oral glucose load less than or equal to 0.033 nmol/l was regarded as complete beta-cell destruction. All 14 patients without HLA-DQA1*0301 had HLA-A24, whereas only 35 of 58 (60.3%) normal controls without HLA-DQA1*0301 and only 72 of 125 (57.6%) IDDM patients with HLA-DQA1*0301 had this antigen (Pc = 0.0256 and Pc = 0.0080, respectively). Delta CPR in IDDM patients with both HLA-DQA1*0301 and HLA-A24 (0.097 +/- 0.163 nmol/L, mean +/- SD, n = 65) were lower than in IDDM patients with HLA-DQA1*0301 only (0.219 +/- 0.237 nmol/L, n = 45, P < 0.0001) and in IDDM patients with HLA-A24 only (0.187 +/- 0.198 nmol/L, n = 14, P = 0.0395). These results indicate that both HLA-DQA1*0301 and HLA-A24 contribute susceptibility to IDDM independently and accelerate beta-cell destruction in an additive manner.
引用
收藏
页码:3721 / 3725
页数:5
相关论文
共 27 条
[1]   DNA typing of the HLA-A gene: Population study and identification of four new alleles in Japanese [J].
Date, Y ;
Kimura, A ;
Kato, H ;
Sasazuki, T .
TISSUE ANTIGENS, 1996, 47 (02) :93-101
[2]   A GENOME-WIDE SEARCH FOR HUMAN TYPE-1 DIABETES SUSCEPTIBILITY GENES [J].
DAVIES, JL ;
KAWAGUCHI, Y ;
BENNETT, ST ;
COPEMAN, JB ;
CORDELL, HJ ;
PRITCHARD, LE ;
REED, PW ;
GOUGH, SCL ;
JENKINS, SC ;
PALMER, SM ;
BALFOUR, KM ;
ROWE, BR ;
FARRALL, M ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE, 1994, 371 (6493) :130-136
[3]  
EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
[4]   A GENE IN THE HLA CLASS-I REGION CONTRIBUTES TO SUSCEPTIBILITY TO IDDM IN THE FINNISH POPULATION [J].
FENNESSY, M ;
METCALFE, K ;
HITMAN, GA ;
NIVEN, M ;
BIRO, PA ;
TUOMILEHTO, J ;
TUOMILEHTOWOLF, E ;
AKERBLOM, HK ;
LOUNAMAA, R ;
TOIVANEN, L ;
FAGERLUND, A ;
FLITTNER, M ;
GUSTAFSSON, B ;
HAGGQVIST, C ;
HAKULINEN, A ;
HERVA, L ;
HILTUNEN, P ;
HUHTAMAKI, T ;
HUTTUNEN, NP ;
HYTTINEN, M ;
JOKI, T ;
JOKISALO, R ;
KAAR, ML ;
KALLIO, S ;
KAPRIO, EA ;
KASKI, U ;
KNIP, M ;
LAINE, L ;
LAPPALAINEN, J ;
MAENPAA, J ;
MAKELA, AL ;
NIEMI, K ;
NIIRANEN, A ;
NUUJA, A ;
OJAJARVI, P ;
OTONKOSKI, T ;
PIHLAJAMAKI, K ;
PONTYNEN, S ;
RAJANTIE, J ;
SANKALA, J ;
SCHUMACHER, J ;
SILLANPAA, M ;
STAHLBERG, MR ;
STRAHLMANN, CH ;
UOTILA, T ;
VARE, M ;
VARIMO, P ;
WETTENSTRAND, G .
DIABETOLOGIA, 1994, 37 (09) :937-944
[5]  
GIPHART MJ, 1992, HLA 1991, P457
[6]   FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES [J].
GJESSING, HJ ;
MATZEN, LE ;
FABER, OK ;
FROLAND, A .
DIABETOLOGIA, 1989, 32 (05) :305-311
[7]  
HARRIS M, 1979, DIABETES, V28, P1039
[8]   ANALYSIS OF FAMILIES AT RISK FOR INSULIN-DEPENDENT DIABETES-MELLITUS REVEALS THAT HLA ANTIGENS INFLUENCE PROGRESSION TO CLINICAL-DISEASE [J].
HONEYMAN, MC ;
HARRISON, LC ;
DRUMMOND, B ;
COLMAN, PG ;
TAIT, BD .
MOLECULAR MEDICINE, 1995, 1 (05) :576-582
[9]   IDENTIFICATION OF A NEW SUSCEPTIBILITY LOCUS FOR INSULIN-DEPENDENT DIABETES-MELLITUS BY ANCESTRAL HAPLOTYPE CONGENIC MAPPING [J].
IKEGAMI, H ;
MAKINO, S ;
YAMATO, E ;
KAWAGUCHI, Y ;
UEDA, H ;
SAKAMOTO, T ;
TAKEKAWA, K ;
OGIHARA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1936-1942
[10]  
Imanishi T., 1992, HLA 1991, P1065